Search Results - "Arenas, Juan I"

Resveratrol inhibits nonalcoholic fatty liver disease in rats by Bujanda, Luis, Hijona, Elizabeth, Larzabal, Mikel, Beraza, Marta, Aldazabal, Pablo, García-Urkia, Nerea, Sarasqueta, Cristina, Cosme, Angel, Irastorza, Belen, González, Alberto, Arenas, Jr, Juan I

“…The prevalence of nonalcoholic fatty liver disease (NAFLD) is high. NAFLD is linked to obesity, diabetes mellitus, and hypertriglyceridemia. Approximately 20%…”
Get full text

Inflammatory Mediators of Hepatic Steatosis by Hijona, Elizabeth, Hijona, Lander, Arenas, Juan I., Bujanda, Luis

“…Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a world-wide public health problem. NAFLD represents a spectrum of disease ranging from “simple…”
Get full text

Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial) by Riaño, Ioana, Martín, Leticia, Varela, Maria, Serrano, Trinidad, Núñez, Oscar, Mínguez, Beatriz, Rodrigues, Pedro M, Perugorria, Maria J, Banales, Jesus M, Arenas, Juan I

“…Pravastatin has demonstrated anti-tumor activity in preclinical and clinical studies. This multicentric randomized double-blind placebo-controlled phase II…”
Get full text

Malignant colorectal polyps by Bujanda, Luis, Cosme, Angel, Gil, Ines, Arenas-Mirave, Juan I

“…Nowadays, the number of cases in which malignant colorectal polyps are removed is increasing due to colorectal cancer screening programmes. Cancerous polyps…”
Get full text

Effect of resveratrol on alcohol-induced mortality and liver lesions in mice by Bujanda, Luis, García-Barcina, María, Gutiérrez-de Juan, Virginia, Bidaurrazaga, Joseba, de Luco, Marian Fernández, Gutiérrez-Stampa, Marian, Larzabal, Mikel, Hijona, Elisabeth, Sarasqueta, Cristina, Echenique-Elizondo, Miguel, Arenas, Juan I

“…Resveratrol is a polyphenol with important antiinflammatory and antioxidant properties. We investigated the effect of resveratrol on alcohol-induced mortality…”
Get full text

Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid by Gomez, Elena, Garcia Buey, Luisa, Molina, Esther, Casado, Marta, Conde, Isabel, Berenguer, Marina, Jorquera, Francisco, Simón, Miguel‐Angel, Olveira, Antonio, Hernández‐Guerra, Manuel, Mesquita, Monica, Presa, Jose, Costa‐Moreira, Pedro, Macedo, Guilherme, Arenas, Juan I., Manuel Sousa, Jose, Ampuero, Javier, Morillas, Rosa M., Santos, Arsenio, De Carvalho, Armando, Uriz, Javier, Carrión, Jose A., Luisa Gutiérrez, Maria, Pérez‐Fernández, Elia, Fernández‐Rodríguez, Conrado M.

“…Summary Background Obeticholic acid (OCA) was recently approved as the only on‐label alternative for patients with primary biliary cholangitis (PBC) with…”
Get full text

A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib by de la Torre, Manuel A., Buades-Mateu, Juan, de la Rosa, Pedro A., Lué, Alberto, Bustamante, Francisco J., Serrano, María T., Testillano, Milagros, Lorente, Sara, Arenas, Juan I., Gil, Cristina, Iñarrairaegui, Mercedes, Sangro, Bruno

“…Background & Aims Sorafenib (SOR) is the standard of care for patients with hepatocellular carcinoma (HCC) and portal vein invasion (PVI), based on the results…”
Get full text

Hepatitis C Virus Quasi-Species Dynamics Predict Progression of Fibrosis after Liver Transplantation by Arenas, Juan I., Gallegos-Orozco, Juan F., Laskus, Tomasz, Wilkinson, Jeff, Khatib, Amer, Fasola, Carlos, Adair, Debra, Radkowski, Marek, Kibler, Karen V., Nowicki, Marek, Douglas, David, Williams, James, Netto, George, Mulligan, David, Klintmalm, Goran, Rakela, Jorge, Vargas, Hugo E.

“…Background. The dynamics of hepatitis C virus (HCV) quasi species in the E2 region may correlate with the course of infection after orthotopic liver…”
Get full text

International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis by Díaz‐González, Álvaro, Sanduzzi‐Zamparelli, Marco, Fonseca, Leonardo G., Di Costanzo, Giovan G., Alves, Rogerio, Iavarone, Massimo, Leal, Cassia, Sacco, Rodolfo, Matilla, Ana M., Hernández‐Guerra, Manuel, Aballay Soteras, Gabriel, Wörns, Marcus‐Alexander, Pinter, Matthias, Varela, María, Ladekarl, Morten, Chagas, Aline L., Mínguez, Beatriz, Arenas, Juan I., Granito, Alessandro, Sánchez‐Torrijos, Yolanda, Rojas, Ángela, Rodríguez de Lope, Carlos, Alvares‐da‐Silva, Mario R., Pascual, Sonia, Rimassa, Lorenza, Lledó, José L., Huertas, Carlos, Sangro, Bruno, Giannini, Edoardo G., Delgado, Manuel, Vergara, Mercedes, Perelló, Christie, Lue, Alberto, Sala, Margarita, Gallego, Adolfo, Coll, Susanna, Hernáez, Tania, Piñero, Federico, Pereira, Gustavo, França, Alex, Marín, Juan, Anders, Margarita, Mello, Vivianne, Lozano, Mar, Nault, Jean C., Menéndez, Josemaría, García Juárez, Ignacio, Bruix, Jordi, Reig, María

“…Background & Aims Information on safety and efficacy of systemic treatment in patients with hepatocellular carcinoma (HCC) under dialysis are limited due to…”
Get full text

Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers by Rodríguez de Lope, Carlos, Reig, María, Matilla, Ana, Ferrer, María Teresa, Dueñas, Eva, Mínguez, Beatriz, F Castroagudín, Javier, Ortiz, Inmaculada, Pascual, Sonia, Lledó, José Luis, Gallego, Adolfo, Arenas, Juan I, Aracil, Carles, Forne, Montserrat, Muñoz, Carolina, Pons, Fernando, Sala, Margarita, Iñarrairaegui, Mercedes, Martin-Llahi, Marta, Andreu, Victoria, Garre, Carmen, Rendón, Paloma, Fuentes, Javier, Crespo, Javier, Rodríguez, Manuel, Bruix, Jordi, Varela, María

“…In 2010 we published that 53% of cases of hepatocellular carcinoma (HCC) detected in Spain were diagnosed outside the context of standard screening programs,…”
Get more information

Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer by Bujanda, Luis, Sarasqueta, Cristina, Zubiaurre, Leire, Cosme, Angel, Muñoz, Carmen, Sánchez, Araceli, Martín, Cristina, Tito, Llucia, Piñol, Virginia, Castells, Antoni, Llor, Xavier, Xicola, Rosa M, Pons, Elisenda, Clofent, Juan, de Castro, María L, Cuquerella, Jaime, Medina, Enrique, Gutierrez, Ana, Arenas, Juan I, Jover, Rodrigo

“…Background:Colonoscopy is one of the methods of choice for screening relatives of patients with colorectal cancer.Objective:To evaluate the rate of adherence…”
Get full text

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis by Calleja, Jose L., Pascasio, Juan M., Ruiz-Antorán, Belén, Gea, Francisco, Bárcena, Rafael, Larrubia, Juan R., Pérez-Álvarez, Ramón, Sousa, Jose M., Romero-Gómez, Manuel, Solá, Ricard, de la Revilla, Juan, Crespo, Javier, Navarro, Jose M., Arenas, Juan I., Delgado, Manuel, Fernández-Rodríguez, Conrado M., Planas, Ramon, Buti, Maria, Forns, Xavier

“…Background & Aims The addition of protease inhibitors (PIs) changed the hepatitis C virus (HCV) treatment standards and improved sustained viral response (SVR)…”
Get full text

Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities by Buti, Maria, Morillas, Rosa M, Pérez, Juan, Prieto, Martín, Solà, Ricard, Palau, Antonio, Diago, Moisés, Bonet, Lucía, Gallego, Adolfo, García-Samaniego, Javier, Testillano, Milagros, Rodríguez, Manuel, Castellano, Gregorio, Gutiérrez, María L, Delgado, Manuel, Mas, Antoni, Romero-Gómez, Manuel, Calleja, José L, González-Guirado, Agustina, Arenas, Juan I, García-Buey, Luisa, Andrade, Raúl, Gila, Ana

“…OBJECTIVESThe aim of this study was to evaluate the efficacy and safety of entecavir monotherapy in nucleos(t)ide-naive chronic hepatitis B patients and to…”
Get full text

M1902 Efficacy and Safety of Entecavir and/or Tenofovir in Hepatitis B Cirrhotic Patients by Miquel, Mireia, Martinez, Oscar Nuñez, Trapero-Marugan, Maria, Diaz-Sanchez, Antonio, Jimenez, Miguel, Arenas, Juan I, Palau, Antonio

Get full text

The use of hepatitis C-infected grafts in liver transplantation by Arenas, Juan I., Vargas, Hugo E., Rakela, Jorge

“…1. Liver grafts from hepatitis C virus (HCV)-infected deceased donors can be used safely in HCV-infected recipients. 2. Histological assessment of the graft…”
Get full text

Hepatitis C virus antiviral therapy in patients with cirrhosis by Arenas, Juan I, Vargas, Hugo E

“…Chronic hepatitis C virus (HCV) infection is generally a slowly progressive disease. A minority of infected patients, however, eventually will develop…”
Get more information

Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes by Horcajada, J P, García-Bengoechea, M, Cilla, G, Etxaniz, P, Cuadrado, E, Arenas, J I

“…In order to analyse the prevalence and significance of cryoglobulinaemia in patients with chronic hepatitis C virus (HCV) infection and the possible…”
Get more information

Late disappearance of hepatitis C virus RNA from peripheral blood mononuclear cells in patients with chronic hepatitis C in sustained response after α-interferon therapy by Garcı́a-Bengoechea, Manuel, Basaras, Miren, Barrio, Jesus, Arrese, Elisabet, Montalvo, Inmaculada I, Arenas, Juan I, Cisterna, Ramon

“…OBJECTIVE: We aimed to investigate the modifications of HCV RNA (genomic and antigenomic strands) in peripheral blood mononuclear cells (PBMCs) of long-term…”
Get full text

Antibacterial Activity of Wine Against Salmonella enteritidis pH or Alcohol? by Marimón, José M, Bujanda, Luis, Gutierrez-Stampa, María A, Cosme, Angel, Arenas, Juan I

Get full text

Helicobacter pylori Infection: A Seroepidemiological Study in Gipuzkoa, Basque Country, Spain by Cilla, Gustavo, Pérez-Trallero, Emilio, García-Bengoechea, Manuel, Marimón, Jose-María, Arenas, Juan I.

“…Helicobacter pylori is one of the most common bacterial infections worldwide. To evaluate the prevalence of this infection in Gipuzkoa (Basque Country, Spain)…”
Get full text